Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Wondering whether Merck at US$128.66 is still offering fair value, or if the recent run means you are paying too much for the stock? The share price moves have been strong, with Merck showing returns ...

View Merck & Co., Inc. MRK stock quote prices, financial information, real-time forecasts, and company news from CNN.

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...

Merck & Co., Inc. (NYSE:MRK) has been on a strong recovery run, gaining 23% over the past year and 8% year-to-date, though the stock has pulled back some, now well below its 52-week high of $125.14.

Joseph Romanelli, President at Merck & Co (NYSE:MRK), reported an insider buy on January 28, according to a new SEC filing. What Happened: Romanelli made a significant move by purchasing 5,703 shares ...

Q1 beat and Bio-Techne deal drive upside, but valuation looks full. Read here for a detailed investment analysis.

It was revealed in a recent SEC filing that Chirfi Guindo, Chief Marketing Officer at Merck & Co (NYSE:MRK) made a noteworthy insider purchase on January 28,. What Happened: In a recent Form 4 filing ...